Amanote Research
Register
Sign In
P1.03-29 an Intronic Variant in EGFR Regulates GBAS Expression and Predicts Survival in Early-Stage Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.710
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
M.J. Hong
S.Y. Lee
S.S. Yoo
E. Lee
J.Y. Park
S. Cho
Publisher
Elsevier BV
Related search
Nuclear EGFR Protein Expression Predicts Poor Survival in Early Stage Non-Small Cell Lung Cancer
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
OA01 LKB1 Pathway Variant TSC2 Rs30259 Predicts the Prognosis in Early Stage Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Social Factors, Treatment, and Survival in Early-Stage Non-Small Cell Lung Cancer.
American Journal of Public Health
Environmental
Public Health
Occupational Health
Peripheral Immune Cell Gene Expression Predicts Survival of Patients With Non-Small Cell Lung Cancer
PLoS ONE
Multidisciplinary
P3.16-42 Early Stage Non-Small Cell Lung Cancer Survival in a Chilean Private Teaching Hospital
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Survival After Surgery in Stage IA and IB Non–Small Cell Lung Cancer
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
EGFR Expression and Survival in Patients Given Cetuximab and Chemoradiation for Stage III Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0324
Radiotherapy and Oncology
Nuclear Medicine
Oncology
Radiology
Hematology
Imaging
Chemotherapy Uptake and Wait Times in Early-Stage Non-Small-Cell Lung Cancer
Current Oncology
Oncology
P3.01-95 EGFR Genotype as a Predictor of Survival in EGFR Mutant Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
